GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Daito Pharmaceutical Co 4577.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,308

+0.31%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥50.65bn

FY2017FY2026

Net income

¥3.16bn

FY2017FY2026

Free cash flow

¥5.53bn

FY2017FY2026

Shareholders' equity

¥52.89bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥50.65bn¥50.64bn¥46.90bn¥45.10bn¥43.46bn¥48.71bn¥45.00bn¥41.14bn¥39.88bn¥37.97bn
Gross profit¥9.90bn¥8.47bn¥9.67bn¥10.15bn¥11.31bn¥10.66bn¥9.37bn¥8.55bn¥7.99bn¥7.54bn
Research and development—¥2.52bn¥2.35bn¥1.86bn¥1.75bn¥2.03bn¥1.40bn¥1.61bn¥1.52bn¥1.27bn
Operating income¥3.64bn¥2.62bn¥3.89bn¥5.21bn¥6.57bn¥5.92bn¥5.36bn¥4.55bn¥4.17bn¥3.88bn
Net income¥3.16bn¥1.91bn¥3.29bn¥3.60bn¥4.67bn¥4.25bn¥3.94bn¥3.51bn¥3.04bn¥2.66bn
Diluted earnings per share111.2264.35107.70113.87146.96139.82130.75125.45110.4996.48

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥73.29bn¥78.00bn¥77.71bn¥70.55bn¥64.94bn¥57.74bn¥54.25bn¥46.75bn¥46.90bn¥45.71bn
Cash and short-term investments¥954.0m¥2.21bn¥2.73bn¥3.61bn¥4.38bn¥3.37bn¥3.08bn¥1.82bn¥1.71bn¥1.62bn
Total liabilities¥20.35bn¥25.93bn¥25.44bn¥19.58bn¥17.26bn¥15.82bn¥17.38bn¥15.40bn¥18.40bn¥19.89bn
Debt¥9.29bn¥11.88bn¥8.72bn¥4.89bn¥3.44bn¥3.38bn¥3.16bn¥5.01bn¥7.40bn¥9.13bn
Shareholders' equity¥52.89bn¥52.00bn¥52.07bn¥50.67bn¥47.31bn¥41.62bn¥36.51bn¥30.94bn¥28.06bn¥25.37bn
Shares outstanding28m30m31m32m32m30m30m28m28m28m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥9.38bn¥5.90bn¥5.18bn¥4.16bn¥4.37bn¥5.18bn¥4.31bn¥6.89bn¥5.47bn¥5.07bn
Capital spending−¥3.85bn−¥6.85bn−¥6.22bn−¥5.50bn−¥4.63bn−¥6.32bn−¥2.73bn−¥3.63bn−¥3.82bn−¥2.99bn
Free cash flow¥5.53bn−¥957.0m−¥1.04bn−¥1.35bn−¥257.0m−¥1.14bn¥1.58bn¥3.26bn¥1.64bn¥2.08bn
Dividends paid−¥1.12bn−¥998.0m−¥907.0m−¥931.0m−¥660.0m−¥658.1m−¥502.1m−¥450.7m−¥412.6m−¥375.3m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue¥11.89bn¥13.92bn¥11.59bn¥12.13bn¥13.01bn¥14.03bn¥12.03bn¥11.91bn
Gross profit¥2.19bn¥2.78bn¥2.35bn¥2.21bn¥2.56bn¥2.26bn¥2.00bn¥2.13bn
Operating income¥713.0m¥884.0m¥1.13bn¥627.0m¥1.00bn¥752.0m¥397.0m¥622.0m
Net income¥701.0m¥893.0m¥1.04bn¥536.0m¥696.0m¥691.0m¥309.0m¥291.0m
Diluted earnings per share24.6631.4236.4518.0823.4723.3010.429.51
Cash from operations—¥9.38bn—————¥920.0m
Capital spending—−¥3.85bn—————−¥2.44bn
Free cash flow—¥5.53bn—————−¥1.52bn
Total assets¥71.65bn¥73.29bn¥74.96bn¥76.84bn¥78.84bn¥78.00bn¥76.63bn¥79.63bn
Cash and short-term investments¥1.69bn¥954.0m¥1.87bn¥2.22bn¥2.15bn¥2.21bn¥2.38bn¥3.24bn
Debt¥3.25bn¥7.07bn¥3.40bn¥8.52bn¥3.49bn¥10.03bn¥3.20bn¥11.32bn
Shareholders' equity¥52.42bn¥52.89bn¥52.26bn¥52.17bn¥52.17bn¥52.00bn¥51.53bn¥52.01bn

Financial ratios

Data as of 19 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin19.5%16.7%20.6%22.5%26.0%21.9%—
Operating margin7.2%6.1%9.1%11.6%15.1%12.1%—
Net margin6.2%3.8%7.0%8.0%10.7%8.7%—
Return on equity6.0%3.7%6.3%7.1%9.9%10.2%—
Return on assets4.3%2.4%4.2%5.1%7.2%7.4%—
Free cash flow yield34.4%32.3%28.0%23.0%21.3%28.5%—
Revenue growth0.0%8.0%4.0%3.8%-10.8%8.2%—
Earnings growth65.7%-42.1%-8.5%-22.9%9.9%7.6%—
Current ratio2.62x2.45x2.24x2.64x2.69x2.52x—
Debt to equity0.13x0.19x0.14x0.09x0.07x0.08x—
Equity ratio72.2%66.7%67.0%71.8%72.8%72.1%—
Interest coverage27.98x25.05x103.88x434.33x730.78x753.67x—
R&D as a share of sales—5.0%5.0%4.1%4.0%4.2%3.1%
Buybacks as a share of market value2.6%3.1%3.2%0.5%-4.6%-0.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.9%0.8%3.4%
Operating income-11.3%-9.3%0.2%
Net income-4.2%-5.7%2.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin18.1%19.8%21.1%20.7%
Operating margin6.2%7.9%9.8%10.2%
Net margin5.0%6.2%7.3%7.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings11.921.19.78.47.79.712.911.512.315.0
Price to sales0.70.80.70.70.80.81.11.00.91.1

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 28 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year40.0050.0028.63629.54521.81822.27318.18216.364
  • 2-for-1 split · 29 May 2025
  • 1.1-for-1 split · 30 Aug 2023
  • 1.1-for-1 split · 27 Mar 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.